METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to find best first chemo for black caribbean women with aggressive breast cancer
Disease control Not yet recruitingThis study compares gemcitabine to the standard drug paclitaxel as first treatment for Black Caribbean women with metastatic triple-negative breast cancer. 750 women from Jamaica, Trinidad, and Barbados will receive one of the two drugs by injection. The goal is to see which drug…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: AntiCancer Research Jamaica • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New pill takes on tough breast cancer in first human trial
Disease control Not yet recruitingThis study tests a new oral drug called Zn-Telomir in people with advanced or metastatic triple-negative breast cancer (TNBC) who have already tried other treatments. The trial has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. About 76 ad…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New drug combo shows promise against tough breast cancer
Disease control Not yet recruitingThis study tests whether adding the experimental drug BEBT-209 to standard chemotherapy (carboplatin and gemcitabine) works better than chemotherapy alone for people with advanced triple-negative breast cancer. About 446 women aged 18-75 will be randomly assigned to one of two gr…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated May 17, 2026 06:44 UTC